Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands	Total	Series D Units	Redemption of Operating Partnership units for stock	Redemption of Operating Partnership units for cash	Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Preferred Operating Partnership	Noncontrolling Interest - Preferred Operating Partnership Series D Units	Noncontrolling Interest - Preferred Operating Partnership Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Operating Partnership	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for stock	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for cash	Noncontrolling Interest - Other	Common Stock	Common Stock Redemption of Operating Partnership units for stock	Additional Paid-in Capital	Additional Paid-in Capital Redemption of Operating Partnership units for stock	Additional Paid-in Capital Redemption of Operating Partnership units for cash	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance, beginning of period at Dec. 31, 2020	$ 2,936,124					$ 172,052			$ 215,892			$ 401	$ 1,314		$ 3,000,458			$ (99,093)	$ (354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020													131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)													56,722
Issuance of common stock upon the exercise of options	4,254														4,254
Issuance of common stock in connection with share based compensation (in shares)													89,793
Issuance of common stock in connection with share based compensation	3,652														3,652
Restricted stock grants cancelled (in shares)													(2,499)
Issuance of common stock, net of offering costs	273,720												$ 22		273,698
Issuance of common stock, net of offering costs (in shares)													2,185,685
Redemption of Operating Partnership units			$ 0							$ (193)						$ 193
Redemption of Operating Partnership units (in shares)														5,000
Noncontrolling interest in consolidated joint venture	(50)											(50)
Net income (loss)	215,501					3,680			8,828			(5)							202,998
Other comprehensive income	23,013					144			956									21,913
Distributions to Operating Partnership units held by noncontrolling interests	(9,025)					(3,224)			(5,801)
Dividends paid on common stock	(132,540)																		(132,540)
Balance, end of period at Mar. 31, 2021	3,314,649					172,652			219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, end of period (in shares) at Mar. 31, 2021													133,692,662
Balance, beginning of period at Dec. 31, 2020	2,936,124					172,052			215,892			401	$ 1,314		3,000,458			(99,093)	(354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020													131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	394,080
Balance, end of period at Jun. 30, 2021	3,360,955					172,902			219,466			499	$ 1,337		3,288,852			(71,830)	(250,271)
Balance, end of period (in shares) at Jun. 30, 2021													133,791,109
Balance, beginning of period at Mar. 31, 2021	3,314,649					172,652			219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, beginning of period (in shares) at Mar. 31, 2021													133,692,662
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)													44,990
Issuance of common stock in connection with share based compensation	4,983														4,983
Restricted stock grants cancelled (in shares)													(4,972)
Offering costs associated with previous stock issuance	(211)														(211)
Redemption of Operating Partnership units				$ (472)						$ (2,185)	$ (113)			$ 1		$ 2,184	$ (359)
Redemption of Operating Partnership units (in shares)														58,429
Repayment of receivable with Operating Partnership units pledged as collateral	411								411
Noncontrolling interest in consolidated joint venture	150											150
Net income (loss)	178,579					3,438			7,190			3							167,948
Other comprehensive income	5,617					35			232									5,350
Distributions to Operating Partnership units held by noncontrolling interests	(8,974)					(3,223)			(5,751)
Dividends paid on common stock	(133,777)																		(133,777)
Balance, end of period at Jun. 30, 2021	3,360,955					172,902			219,466			499	$ 1,337		3,288,852			(71,830)	(250,271)
Balance, end of period (in shares) at Jun. 30, 2021													133,791,109
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976					259,110			410,053			317	$ 1,339		3,285,948			(42,546)	(128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021	133,922,305												133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)													142,784
Issuance of common stock in connection with share based compensation	$ 4,542														4,542
Restricted stock grants cancelled (in shares)													(779)
Redemption of Operating Partnership units				(2,672)	$ (3,375)			$ (3,375)			(829)						(1,843)
Issuance of common stock in conjunction with acquisitions	40,965												$ 4		40,961
Issuance of common stock in conjunction with acquisitions (in shares)													186,766
Net income (loss)	217,717					4,333			9,805										203,579
Other comprehensive income	51,649					313			2,333									49,003
Distributions to Operating Partnership units held by noncontrolling interests	(14,111)					(4,330)			(9,781)
Dividends paid on common stock	(202,527)																		(202,527)
Balance, end of period at Mar. 31, 2022	3,878,164					256,051			411,581			317	$ 1,343		3,329,608			6,457	(127,193)
Balance, end of period (in shares) at Mar. 31, 2022													134,251,076
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976					259,110			410,053			317	$ 1,339		3,285,948			(42,546)	(128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021	133,922,305												133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Buyback of common stock, net of offering costs	$ (63,008)
Buyback of common stock, net of offering costs (in shares)	(381,786)
Net income (loss)	$ 465,551
Balance, end of period at Jun. 30, 2022	$ 3,893,240					261,231			429,572			317	$ 1,339		3,334,317			25,555	(159,091)
Balance, end of period (in shares) at Jun. 30, 2022	133,900,184												133,900,184
Balance, beginning of period at Mar. 31, 2022	$ 3,878,164					256,051			411,581			317	$ 1,343		3,329,608			6,457	(127,193)
Balance, beginning of period (in shares) at Mar. 31, 2022													134,251,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)													38,016
Issuance of common stock in connection with share based compensation	5,245														5,245
Restricted stock grants cancelled (in shares)													(7,122)
Redemption of Operating Partnership units				$ (832)	$ (1,125)			$ (1,125)			$ (296)						$ (536)
Issuance of noncontrolling interests in conjunction with business combinations	16,000	$ 6,000					$ 6,000		16,000
Buyback of common stock, net of offering costs	(63,008)												$ (4)						(63,004)
Buyback of common stock, net of offering costs (in shares)													(381,786)
Net income (loss)	247,834					4,491			11,213										232,130
Other comprehensive income	20,113					120			895									19,098
Distributions to Operating Partnership units held by noncontrolling interests	(14,127)					(4,306)			(9,821)
Dividends paid on common stock	(201,024)																		(201,024)
Balance, end of period at Jun. 30, 2022	$ 3,893,240					$ 261,231			$ 429,572			$ 317	$ 1,339		$ 3,334,317			$ 25,555	$ (159,091)
Balance, end of period (in shares) at Jun. 30, 2022	133,900,184												133,900,184